By Intrepid Investor : The recent selloff of biotech and small cap stocks was so rapid that I could not decide fast enough which individual stocks to buy with one exception: Gilead ( GILD ). So when it looked like the stampede out of biotech might be over, I parked my cash in iShares NASDAQ ...
By C.R. Jackson : Cambridge, Massachusetts-based bluebird bio ( BLUE ) is a $710M market cap clinical-stage biotechnology company that is developing gene therapies for severe genetic and orphan diseases. Founded in 1992, the company was formerly known as Genetix Pharmaceuticals, Inc . The company's
We are no longer providing equity research on Vical VICL . We provide broad coverage of more than 1,800 companies across 91 industry groups and adjust our coverage as necessary based on client demand and investor interest.
Vical VICL has reported positive preclinical results from its H1N1 swine flu vaccine, but we will maintain our fair value estimate until